IPSC
Century Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.62 / 10
Outperform
Analyst consensus is fully bullish (Buy 100%) from Piper Sandler, with a 1‑analyst track record of 100% win rate. Fund‑flow score is 7.68 (good), showing modest overall inflow (≈0.50) and positive small‑investor trend, though larger blocks trend negative.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-20
InstitutionPiper Sandler
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for IPSC?
- IPSC holds a Bullish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.62/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
